Home > Newsletters > The QMN Weekly Bulletin > Ben Venue’s Bedford Plant Resumes Producing Some Generic Injectables
The QMN Weekly Bulletin
Oct. 26, 2012 | Vol. 4 No. 43
Ben Venue’s Bedford Plant Resumes Producing Some Generic Injectables
Ben Venue’s Bedford, Ohio, plant — in the news this past year for quality problems — has restarted a handful of production lines to make some of its critical-need drugs available again. Injectable generics such as radiotherapy drug amifostine, muscle relaxant vecuronium, chemotherapy drug gemcitabine and vasodilator phentolamine are once more returning to market shelves.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.